Arena Pharmaceuticals Inc
ARNA
ARNA was delisted on the 10th of March, 2022.
226 hedge funds and large institutions have $1.92B invested in Arena Pharmaceuticals Inc in 2019 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 81 increasing their positions, 71 reducing their positions, and 32 closing their positions.
14% more repeat investments, than reductions
Existing positions increased: 81 | Existing positions reduced: 71
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
2% less capital invested
Capital invested by funds: $1.96B → $1.92B (-$39.1M)
6% less first-time investments, than exits
New positions opened: 30 | Existing positions closed: 32
2% less funds holding
Funds holding: 230 → 226 (-4)
36% less call options, than puts
Call options by funds: $18.9M | Put options by funds: $29.3M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$10.5M |
| 2 |
Man Group
London,
United Kingdom
|
+$9.84M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$8.09M |
| 4 |
PM
Prosight Management
Dallas,
Texas
|
+$7.8M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$7.36M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$56.8M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
-$13.6M |
| 3 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
-$13.2M |
| 4 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
-$12.9M |
| 5 |
State Street
Boston,
Massachusetts
|
-$8.1M |
ARNA Hedge Fund Activity: Q4 2019 in Review
226 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Arena Pharmaceuticals Inc (ARNA) for Q4 2019, worth a combined $1.92B — down 2% from $1.96B a quarter earlier.
Sellers outnumbered buyers: 32 funds closed out of ARNA and 30 opened new positions — a net loss of 2 holders — while 71 trimmed existing stakes and 81 added.
The largest buyer was Panagora Asset Management, adding an estimated $10.5M. The largest seller was PFM Health Sciences, cutting an estimated $56.8M.
- 226 institutional investors held Arena Pharmaceuticals Inc (ARNA) as of Q4 2019, down from 230 in Q3 2019.
- Funds reported $1.92B of Arena Pharmaceuticals Inc stock for Q4 2019, down 2% quarter-over-quarter.
- 30 funds opened new Arena Pharmaceuticals Inc positions in Q4 2019 and 32 closed out, a net change of -2 holders.
- The largest Arena Pharmaceuticals Inc buyer in Q4 2019 was Panagora Asset Management, an estimated $10.5M added.
- The largest Arena Pharmaceuticals Inc seller in Q4 2019 was PFM Health Sciences, an estimated $56.8M sold.
Based on aggregated 13F filings for Q4 2019.